The Trump administration just made the biggest shift in federal drug policy in decades. Here’s what it means for Topeka — and why Kansas is still on the outside looking in.
By This Is Topeka Staff | April 27, 2026
For the first time in more than 50 years, the federal government is acknowledging what millions of Americans have long known: marijuana has legitimate medical value.
On April 22, the U.S. Department of Justice issued an order immediately reclassifying state-licensed medical marijuana from Schedule I — a category it shared with heroin and LSD — to the less restrictive Schedule III of the Controlled Substances Act. For advocates, researchers, and patients across the country, it’s being called a watershed moment.
For Kansans, the reaction is more complicated: hopeful, but tempered by the reality that our state remains one of the very last in the nation to deny residents access to medical cannabis at all.
What Changed — and Why It Matters
The rescheduling order, signed by Acting Attorney General Todd Blanche, applies to two categories of marijuana products: those that are FDA-approved, and those sold through a state-licensed medical marijuana program. The move fulfills a directive from a December 2025 executive order by President Trump to accelerate rescheduling.
The practical effects are significant for the 40 states that already have medical cannabis programs. Businesses that operate legally under state law will now be able to deduct ordinary business expenses from their federal taxes — a benefit previously denied under a tax provision called Section 280E. Experts estimate this alone could cut effective tax rates for medical cannabis operators from as high as 70–80% down to 20–30%.
Perhaps even more importantly, researchers will no longer need a burdensome Schedule I license to study cannabis products available in state markets. That change could finally allow the kind of rigorous clinical research that patients and physicians have been asking for — research into conditions like chronic pain, PTSD, epilepsy, and more.
“Today’s order marks a historical reversal in federal cannabis policy. It validates the experiences of tens of millions of Americans, as well as those of tens of thousands of physicians, who have long recognized that cannabis possesses legitimate medical utility.”— NORML Deputy Director Paul Armentano
The Kansas Reality Check
Here’s the hard truth: none of those direct benefits apply to Kansas yet.
Kansas has no medical marijuana program. It is one of only two states in the entire country — alongside Idaho — with an outright ban on both medical and recreational cannabis. There are no licensed dispensaries. There are no state-licensed products. The federal rescheduling order, by its own terms, only applies where a state medical program already exists.
The Kansas Bureau of Investigation issued a statement the same day as the federal order, making its position clear: marijuana remains just as illegal in Kansas as it was before, and the KBI will continue to enforce state law. KBI Director Tony Mattivi, who has been a vocal opponent of cannabis reform, said his position has not changed.
Under current Kansas law, even first-time possession can result in up to six months in jail and a $1,000 fine. The only narrow protection on the books is a 2019 affirmative defense for CBD products containing no more than 5% THC — far short of a meaningful medical program.
But the Momentum Is Building
None of that means advocates are giving up — or that change isn’t coming.
In early 2026, Kansas lawmakers introduced two new cannabis bills in the House: HB 2678, the Kansas Medical Cannabis Act, and HB 2679, which would legalize adult-use cannabis. Both were referred to the House Federal and State Affairs Committee. A similar medical cannabis bill, SB 294, was introduced in the Senate in 2025 and remains in play for the current two-year legislative session.
Meanwhile, Wichita dispensary owner Brett Harris put it plainly after Thursday’s announcement: “It’s a domino effect. You have to have this guy on the federal level actually start to fall in regulations. It’s a great first step.”
State Sen. Cindy Holscher, a Democrat from Overland Park, echoed that sentiment: “I applaud the administration for making this change. Medicinal cannabis is finally being acknowledged at the federal level as having health benefits.”
“The state of Kansas has to pass their own law to make sure that shift comes from I to III. When will that happen, on a state level? Who knows.”— Brett Harris, owner, Kannabliss dispensary, Wichita
The federal rescheduling also sets up a broader hearing starting June 29, when the DEA will examine rescheduling all marijuana — including products not covered by state medical programs. That process could further shift the national conversation in ways that put pressure on holdout states like Kansas.
What Topeka Residents Should Know
If you or a family member have been hoping for access to medical cannabis in Kansas, this moment is meaningful — not because it changes anything today, but because it changes the national story. The federal government is no longer pretending marijuana has no medical use. That argument has been central to Kansas opponents for years.
The path forward in Kansas still runs entirely through the legislature, since the state does not allow citizen ballot initiatives for cannabis. That means contacting your state representative and senator remains the most direct way for Topekans to influence whether — and when — Kansas finally joins the rest of the country.
Where Things Stand: Kansas Cannabis at a Glance
- Medical marijuana:Illegal(no state program)
- Recreational marijuana:Illegal
- CBD with up to 5% THC: Limited affirmative defense only
- Pending legislation: HB 2678 (medical), HB 2679 (adult-use), SB 294 (medical) — all in committee
- Federal rescheduling impact on Kansas today:None — until the state acts
- Next federal step: DEA hearing on broader rescheduling begins June 29, 2026
For the 40 states with medical cannabis programs, last week’s announcement is a long-awaited validation and a financial lifeline for an industry that has operated under enormous federal tax penalties. For Kansas, it is something else: a signpost pointing toward a destination the state has not yet chosen to reach.
The question is no longer whether the country is moving in this direction. It’s whether Kansas will keep making its residents travel across the border to get the care they need — or finally take the step that 40 other states already have.
Tags: Kansas, marijuana, medical cannabis, federal policy, Topeka, KBI, legislature
